Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Saracchini

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Investigation|January 1, 1991
Evaluation of two consecutive regimens in advanced gastric cancerF Figoli, E Galligioni, D Crivellari, et al.
Cancer Detection and Prevention|January 1, 1988
Clinical and laboratory findings at presentation in persistent generalized lymphadenopathy vs malignant lymphomaV Zagonel, U Tirelli, E Vaccher, et al.
Future Oncology (London, England)|February 25, 2015
Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patientsG Mustacchi, F Puglisi, A M Molino, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2011
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancerD Amadori, C Milandri, G Comella, et al.
British Journal of Cancer|July 30, 2005
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II studyP F Conte, S Donati, A Gennari, et al.
Breast (Edinburgh, Scotland)|August 31, 2019
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 studyM E Cazzaniga, G Pinotti, E Montagna, et al.
Breast Cancer Research and Treatment|September 21, 2021
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 studyM E Cazzaniga, I Vallini, E Montagna, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Investigation|January 1, 1991
Evaluation of two consecutive regimens in advanced gastric cancerF Figoli, E Galligioni, D Crivellari, et al.
Cancer Detection and Prevention|January 1, 1988
Clinical and laboratory findings at presentation in persistent generalized lymphadenopathy vs malignant lymphomaV Zagonel, U Tirelli, E Vaccher, et al.
Future Oncology (London, England)|February 25, 2015
Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patientsG Mustacchi, F Puglisi, A M Molino, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2011
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancerD Amadori, C Milandri, G Comella, et al.
British Journal of Cancer|July 30, 2005
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II studyP F Conte, S Donati, A Gennari, et al.
Breast (Edinburgh, Scotland)|August 31, 2019
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 studyM E Cazzaniga, G Pinotti, E Montagna, et al.
Breast Cancer Research and Treatment|September 21, 2021
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 studyM E Cazzaniga, I Vallini, E Montagna, et al.
Pageof 2